HDA Blog

The coronavirus pandemic fostered and underscored the benefits of public-private partnerships as healthcare supply chain companies used their expertise and strengths to support the government’s response to an ongoing health crisis. The Milken Institute’s “2021 Partnering for Patients Forum” explored this topic during a panel discussion entitled, “Reimagining Public Health Partnerships: Lessons Learned from the Pandemic.”

Events spanning COVID-19 vaccine distribution to shipping containers held up at port have made the supply chain a “kitchen-table” issue during the past year. Many industries experienced notable disruptions in their delivery of goods and supplies; however, as noted by President and CEO Chip Davis, “[P]harmacies, health systems and physicians’ offices, more than 180,000 across the country, remain stocked with the lifesaving medications and vaccines patients need. That didn’t happen by accident.” Davis’ perspective was featured alongside healthcare supply chain association leaders as part of Chain Drug Review’s annual “Pharmacy Outlook” feature.

Protecting the health of Americans begins with ensuring the well-being of our planet — and healthcare distributors recognize the industry’s responsibility to drive meaningful action on reducing climate change.

The two-year countdown to the Drug Supply Chain Security Act (DSCSA) deadline has begun. This final milestone, in combination with those already completed, will fundamentally change how product and data move together across the healthcare supply chain.

On October 7, HDA launched a three-part series to showcase how the distribution industry is helping create healthier communities through philanthropy, employee activism, partnerships with nonprofit organizations and more.

HDA President and CEO Chip Davis participated in the Aspen Institute’s 2021 Aspen Security Forum as part of a panel discussion entitled, "Building a More Resilient Global Supply Chain."

October marks American Pharmacists Month, an important opportunity to recognize the profound contribution of dedicated pharmacists who work on the frontlines of U.S. healthcare on a daily basis.

On October 7, we launched a three-part series to showcase how the distribution industry is making a difference in local communities across the country. In part one, we explored how HDA’s distributor members are leaving their imprint upon communities through corporate, foundation and employee support.

Long before the COVID-19 pandemic, HDA healthcare distributors recognized the vital role that philanthropy plays in building healthier communities — and the industry’s responsibility in leading these efforts. 

Since the Drug Supply Chain Security Act (DSCSA) was enacted nearly 10 years ago, healthcare supply chain stakeholders have made steady progress in meeting regularly (through HDA and other settings) to discuss compliance strategies, establish recommended guidelines and build consensus on key milestones.